Overview
Availability
- Honorary Professor Josephine Forbes is:
- Available for supervision
Qualifications
- Bachelor, University of Melbourne
- Doctor of Philosophy, University of Melbourne
Works
Search Professor Josephine Forbes’s works on UQ eSpace
2007
Conference Publication
Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes
Coughlan, M. T., Forbes, J. M. and Cooper, M. E. (2007). Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes. 5th Hyonam-Kidney-Laboratory-International-Diabetes Symposium, Seoul South Korea, Feb 02-03, 2007. Nature Publishing Group. doi: 10.1038/sj.ki.5002387
2007
Journal Article
Diabetic nephropathy: where hemodynamics meets metabolism
Forbes, J. M., Fukami, K. and Cooper, M. E. (2007). Diabetic nephropathy: where hemodynamics meets metabolism. Experimental and Clinical Endocrinology and Diabetes, 115 (2), 69-84. doi: 10.1055/s-2007-949721
2006
Journal Article
Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease
Burns, Wendy C., Twigg, Stephen M., Forbes, Josephine M., Pete, Josefa, Tikellis, Christos, Thallas-Bonke, Vicki, Thomas, Merlin C., Cooper, Mark E. and Kantharidis, Phillip (2006). Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. Journal of the American Society of Nephrology, 17 (9), 2484-2494. doi: 10.1681/ASN.2006050525
2006
Conference Publication
Diabetes-induced effects on endothelial function and the actions of nitric oxide
Soro-Paavonen, A., Zhang, W. -Z., Venardos, K., Jones, E., Chin-Dusting, J., Thomas, M. T., Coughlan, M. T., Brasacchio, D., Cooper, M. E., Kaye, D. and Forbes, J. M. (2006). Diabetes-induced effects on endothelial function and the actions of nitric oxide. 42nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Copenhagen Denmark, Sep 14-17, 2006. SPRINGER.
2006
Journal Article
A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products
Zimanyi, M. A., Denton, K. M., Forbes, J. M., Thallas-Bonke, V., Thomas, M. C., Poon, F. and Black, M. J. (2006). A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products. Diabetologia, 49 (4), 801-810. doi: 10.1007/s00125-006-0175-x
2006
Journal Article
Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823))
Forbes, J. M., Yee, L. T.L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., Cooper, M. E. and Allen, T. J. (2006). Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823)). Diabetes, 55 (3)
2006
Journal Article
Novel therapeutics for diabetic micro- and macrovascular complications
Soro-Paavonen, A. and Forbes, J. M. (2006). Novel therapeutics for diabetic micro- and macrovascular complications. Current Medicinal Chemistry, 13 (15), 1777-1788. doi: 10.2174/092986706777452515
2005
Conference Publication
Advanced glycation end products and diabetic nephropathy
Thomas, Merlin C., Forbes, Josephine M. and Cooper, Mark E. (2005). Advanced glycation end products and diabetic nephropathy. doi: 10.1097/01.mjt.0000178769.52610.69
2005
Journal Article
Interactions between renin angiotensin system and advanced glycation in the kidney
Thomas, Merlin C., Tikellis, Christos, Burns, Wendy M., Bialkowski, Katarzyna, Cao, Zemin, Coughlan, Melinda T., Jandeleit-Dahm, Karen, Cooper, Mark E. and Forbes, Josephine M. (2005). Interactions between renin angiotensin system and advanced glycation in the kidney. Journal of the American Society of Nephrology, 16 (10), 2976-2984. doi: 10.1681/ASN.2005010013
2005
Journal Article
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects
Calkin, Anna C., Forbes, Josephine M., Smith, Craig M., Lassila, Markus, Cooper, Mark E., Jandeleit-Dahm, Karin A. and Allen, Terri J. (2005). Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arteriosclerosis, Thrombosis, and Vascular Biology, 25 (9), 1903-1909. doi: 10.1161/01.ATV.0000177813.99577.6b
2005
Journal Article
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy
Forbes, Josephine M., Thorpe, Suzanne R., Thallas-Bonke, Vicki, Pete, Josefa, Thomas, Merlin C., Deemer, Elizabeth R., Bassal, Sahar, El-Osta, Assam, Long, David M., Panagiotopoulos, Sianna, Jerums, George, Osicka, Tanya M. and Cooper, Mark E. (2005). Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. Journal of the American Society of Nephrology, 16 (8), 2363-2372. doi: 10.1681/ASN.2005010062
2005
Journal Article
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction
Kooptiwut, Suwattanee, Kebede, Melkam, Zraika, Sakeneh, Visinoni, Sherley, Aston-Mourney, Kathryn, Favaloro, Jenny, Tikellis, Chris, Thomas, Merlin C., Forbes, Josephine M., Cooper, Mark E., Dunlop, Marjorie, Proietto, Joseph and Andrikopoulos, Sofianos (2005). High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. Journal of Molecular Endocrinology, 35 (1), 39-48. doi: 10.1677/jme.1.01720
2005
Journal Article
Agents in development for the treatment of diabetic nephropathy
Fukami, Kei, Cooper, Mark and Forbes, Josephine M. (2005). Agents in development for the treatment of diabetic nephropathy. Expert Opinion On Investigational Drugs, 14 (3), 279-294. doi: 10.1517/13543784.14.3.279
2005
Conference Publication
Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes
Coughlan, MT, Thorburn, DR, Fukami, K, Laskowski, A, Thallas-Bonke, V, Long, DM, Brownlee, M, Cooper, ME and Forbes, JM (2005). Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.
2005
Journal Article
Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system
Rizkalla, Bishoy, Forbes, Josephine M., Cao, Zemin, Boner, Geoffrey and Cooper, Mark E. (2005). Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. Journal of Hypertension, 23 (1), 153-164. doi: 10.1097/00004872-200501000-00026
2005
Journal Article
Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy
Thomas, M. C., Forbes, J. M. and Cooper, M. E. (2005). Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy. Annals of the New York Academy of Sciences, 1043 (1), 927-927. doi: 10.1196/annals.1333.141
2005
Conference Publication
Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?
Forbes, JM, Coughlan, MT, Fukami, K, Laskowski, A, Thallas-Bonke, V, Dinh, D, Long, DM, Brownlee, M, Cooper, ME and Thorburn, DR (2005). Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.
2005
Conference Publication
Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?
Thomas, Merlin C., Forbes, Josephine M., MacIsaac, Richard, Jerums, George and Cooper, Mark E. (2005). Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?. New York Academy of Sciences. doi: 10.1196/annals.1333.073
2005
Conference Publication
Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?
Coughlan, Melinda T., Cooper, Mark E. and Forbes, Josephine M. (2005). Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?. New York Academy of Sciences. doi: 10.1196/annals.1333.087
2005
Conference Publication
Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists
Cooper, ME, Forbes, JM, Smith, CM, Lassila, M, Jandeleit-Dahm, KA, Allen, TJ and Calkin, AC (2005). Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.
Funding
Current funding
Supervision
Availability
- Honorary Professor Josephine Forbes is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
sRAGE as a preventative therapy for T1D and potential biomarker of pregnancy complications
Principal Advisor
Other advisors: Dr Amelia Fotheringham, Professor Emma Hamilton-Williams, Dr Irina Buckle, Dr Sherman Leung
-
Doctor Philosophy
New insights into molecular pathways involved in the development of diabetic kidney disease: Towards earlier disease detection and identification of novel therapeutic targets
Principal Advisor
Other advisors: Associate Professor Ross Francis
-
Doctor Philosophy
Early mitochondrial dysfunction in diabetic kidney
Principal Advisor
Other advisors: Dr Amelia Fotheringham, Dr Irina Buckle
-
Doctor Philosophy
Unravelling the role of abnormal glycogen accumulation in diabetic kidney disease
Associate Advisor
-
Doctor Philosophy
The Characterisation of Immune Cells in Response To RAGE Antagonism Therapy in Mouse Models of Type 1 Diabetes
Associate Advisor
Other advisors: Dr Zhian Chen, Dr Irina Buckle
Completed supervision
-
2021
Doctor Philosophy
Mitochondrial dysfunction as a pathological mediator in diabetic kidney disease
Principal Advisor
-
2020
Doctor Philosophy
The role of receptor for advanced glycation end products (RAGE) in the development of type 1 diabetes
Principal Advisor
Other advisors: Honorary Professor Kristen Radford, Dr Danielle Borg
-
2020
Doctor Philosophy
Novel dietary factors in diabetic and non-diabetic kidney disease
Principal Advisor
Other advisors: Honorary Professor Michael McGuckin, Dr Danielle Borg
-
2018
Doctor Philosophy
Novel role of AGE-R1/OST48 in the metabolome and proteome promoting ER stress in the kidney and liver
Principal Advisor
Other advisors: Professor Benjamin Schulz
-
2023
Doctor Philosophy
Kidneys on fire: The role of inflammasome signalling in human chronic kidney disease
Associate Advisor
Other advisors: Dr Andrew Kassianos
-
2019
Doctor Philosophy
Nutritional management of hyperglycaemia in intensive care medicine
Associate Advisor
Other advisors: Professor David Sturgess
Media
Enquiries
For media enquiries about Honorary Professor Josephine Forbes's areas of expertise, story ideas and help finding experts, contact our Media team: